These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18783531)

  • 81. Testosterone supplementation in women: prescribing practices in one community.
    Freeman MP
    J Womens Health (Larchmt); 2004 Mar; 13(2):239-40. PubMed ID: 15072739
    [No Abstract]   [Full Text] [Related]  

  • 82. Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women.
    Rowen TS; Davis SR; Parish S; Simon J; Vignozzi L
    J Sex Med; 2020 Apr; 17(4):585-594. PubMed ID: 32063470
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The causes and prevalence of hypoactive sexual desire disorder: part I.
    Feldhaus-Dahir M
    Urol Nurs; 2009; 29(4):259-60, 263. PubMed ID: 19718942
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial.
    de Souza KZ; Vale FB; Geber S
    Menopause; 2016 Nov; 23(11):1252-1256. PubMed ID: 27760089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
    Davis SR; Baber R; Panay N; Bitzer J; Perez SC; Islam RM; Kaunitz AM; Kingsberg SA; Lambrinoudaki I; Liu J; Parish SJ; Pinkerton J; Rymer J; Simon JA; Vignozzi L; Wierman ME
    J Sex Med; 2019 Sep; 16(9):1331-1337. PubMed ID: 31488288
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women.
    Jayasena CN; Alkaabi FM; Liebers CS; Handley T; Franks S; Dhillo WS
    Clin Endocrinol (Oxf); 2019 Mar; 90(3):391-414. PubMed ID: 30488972
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire.
    Chudakov B; Ben Zion IZ; Belmaker RH
    J Sex Med; 2007 Jan; 4(1):204-208. PubMed ID: 17233786
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of testosterone in menopausal hormone treatment. What is the evidence?
    Johansen N; Lindén Hirschberg A; Moen MH
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):966-969. PubMed ID: 32027015
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Female sexual dysfunction and postmenopausal androgen therapy].
    Delcominette S; Gaspard U
    Rev Med Liege; 2008 Jan; 63(1):23-30. PubMed ID: 18303682
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Libido loss after total surgery. Testosterone patch increases sexual desire].
    Schwenkhagen A
    MMW Fortschr Med; 2006 Nov; 148(47):48-9. PubMed ID: 17168190
    [No Abstract]   [Full Text] [Related]  

  • 91. Androgens and Female Sexual Function and Dysfunction--Findings From the Fourth International Consultation of Sexual Medicine.
    Davis SR; Worsley R; Miller KK; Parish SJ; Santoro N
    J Sex Med; 2016 Feb; 13(2):168-78. PubMed ID: 26953831
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Androgen therapy in women: for whom and when.
    Pluchino N; Carmignani A; Cubeddu A; Santoro A; Cela V; Errasti T
    Arch Gynecol Obstet; 2013 Oct; 288(4):731-7. PubMed ID: 23912530
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Testosterone Therapy: Review of Clinical Applications.
    Petering RC; Brooks NA
    Am Fam Physician; 2017 Oct; 96(7):441-449. PubMed ID: 29094914
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Global consensus statement on testosterone therapy for women: an Australian perspective.
    Jang C; Boyle JA; Vincent A
    Med J Aust; 2020 Nov; 213(10):449-452.e1. PubMed ID: 33131104
    [No Abstract]   [Full Text] [Related]  

  • 95. Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder.
    Palacios S; Graziottin A
    Maturitas; 2009 Jun; 63(2):164-8. PubMed ID: 19487091
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Androgenic hormones and aging--the link with female sexual function.
    Davison SL; Davis SR
    Horm Behav; 2011 May; 59(5):745-53. PubMed ID: 21215268
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacologic therapeutic options for sexual dysfunction.
    Burton CS; Mishra K
    Curr Opin Obstet Gynecol; 2022 Dec; 34(6):402-408. PubMed ID: 36036468
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Circle of Female Sexual Desire-Have We Come a Long Way?
    Katz A
    Nurs Womens Health; 2016; 20(3):235-8. PubMed ID: 27287350
    [TBL] [Abstract][Full Text] [Related]  

  • 99. 'Off-label' drug use in sexual medicine treatment.
    Fallon B
    Int J Impot Res; 2008; 20(2):127-34. PubMed ID: 17851582
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical management of hypoactive sexual desire disorder.
    Kingsberg S; Faubion S
    Menopause; 2019 Feb; 26(2):217-219. PubMed ID: 30422931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.